English | Español
Patient Daily | Feb 9, 2026

Penn Medicine scientists use advanced imaging tools for flu and cancer drug discovery
Patient Daily | Feb 9, 2026

Study finds hundreds of potential food allergy risks but rules out vaccine connection
Patient Daily | Feb 9, 2026

Companies advance new Duchenne muscular dystrophy treatments amid scrutiny over existing gene therapies
Patient Daily | Feb 9, 2026

Penn Medicine researchers use advanced imaging tools to reveal disease mechanisms
Patient Daily | Feb 9, 2026

FARE urges further action after Congress passes PBM reform affecting epinephrine access
Patient Daily | Feb 9, 2026

FDA faces major leadership turnover and regulatory shifts following Trump administration actions
Patient Daily | Feb 8, 2026

AstraZeneca acquires full rights to AbelZeta’s cancer therapy for $630 million
Patient Daily | Feb 8, 2026

GSK acquires RAPT Therapeutics for $2.2B under new CEO Luke Miels

Trending
+ Pharmaceuticals
Patient Daily | Apr 5, 2026

Amplifon announces $2 billion acquisition of GN Hearing in strategic shift
Patient Daily | Apr 7, 2026

ProPublica examines impact of RFK Jr.'s vaccine policies on childhood disease risks
+ Pharmaceuticals
Patient Daily | Apr 1, 2026

Biopharma mergers and acquisitions reach $46.8 billion in first quarter of 2026
+ Regulatory
Patient Daily | Apr 8, 2026

Columbia University Professor Masia on 340B: '340B has become a drug mark-up program. Hospitals buy drugs at low cost and sell them high'